Geode Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$60K Sell
2019
Q3
$551K Sell
2019
Q2
$975K Buy
2019
Q1
$438K Buy
2018
Q4
$331K Buy
2018
Q3
$1.6M Buy
2018
Q2
$2.22M Buy
2018
Q1
$1.03M Buy
2017
Q4
$1.27M Buy